Şunu aradınız:: myoclonic (İngilizce - Litvanca)

myoclonic epilepsy
epilepsija.

juvenile myoclonic epilepsy.
mioklonine epilepsija.

years of age with juvenile myoclonic epilepsy,
priepuolius (trumpalaikius, staigius raumen ar raumen grups trkciojimus) ,

the majority of patients presented with juvenile myoclonic epilepsy.
dauguma pacient sirgo jaunatvine mioklonine epilepsija.

the efficacy and safety of perampanel in patients with myoclonic seizures have not been established.
perampanelio veiksmingumas ir saugumas pacientams, kuriems pasireiškia miokloniniai priepuoliai, neištirti.

· in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with
· gydant miokloninius traukulius suaugusiems ir paaugliams nuo 12 met amziaus su juveniline

· in the treatment of myoclonic seizures in patients from 12 years of age wit juvenile myoclonic
· gydant miokloninius traukulius ligoniams nuo 12 met amziaus su juveniline mioklonine

in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.
gydant miokloninius traukulius suaugusiems ir paaugliams nuo 12 metų amžiaus su juveniline mioklonine epilepsija.

adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.
papildomas suaugusij ir paaugli nuo 12 met amziaus, serganci jaunatvine mioklonine epilepsija, mioklonini traukuli gydymas:

juvenile myoclonic epilepsy, and primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy.
generalizacija ar be jos pacientams nuo 16 metų, kuriems epilepsija diagnozuota neseniai, taip pat kaip papildoma priemonė, gydant miokloninius priepuolius pacientams, sergantiems juveniline mioklonine epilepsija, ir gydant pirminius generalizuotus toninius- kloninius priepuolius pacientams, sergantiems idiopatine generalizuota epilepsija.

juvenile myoclonic epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
gydant miokloninius traukulius suaugusiesiems ir paaugliams nuo 12 metų amžiaus su juveniline mioklonine epilepsija. gydyti suaugusiųjų ir nuo 12 metų amžiaus, sergančių idiopatine generalizuota epilepsija, pirminius generalizuotus toninius-kloninius traukulius.

· myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in patients from 12
· suaugusi bei paaugli nuo 12 met, serganci juveniline mioklonine epilepsija, miokloninius

in myoclonic seizures, the effectiveness of keppra was studied in 122 patients, who received either keppra or placebo in addition to their normal anti-epileptic medicine.
keppra veiksmingumas, gydant miokloninius traukulius, buvo tirtas 122 pacientams, kurie be prast vaist nuo epilepsijos vartojo keppra arba placeb.

58.3 % of the levetiracetam treated patients and 23.3 % of the patients on placebo had at least a 50 % reduction in myoclonic seizure days per week.
58,3 % levetiracetamu gydytų pacientų ir 23,3 % placebo pacientų mažiausiai 50 % sumažėjo dienų, kai įvyksta miokloniniai traukuliai.

the incidence of undesirable effects in patients with myoclonic seizures was lower than that in adult patients with partial onset seizures (33.3% versus 46.4%) .
nepageidaujam poveiki daznis pacientams, sergantiems miokloniniais traukuliais buvo mazesnis nei suaugusiems su zidinine epilepsija (33, 3% pries 46, 4%) .

with continued long-term treatment, 28.6% of the patients were free of myoclonic seizures for at least 6 months and 21.0% were free of myoclonic seizures for at least 1 year.
esant nepertraukiamam, ilgalaikiam gydymui, 28, 6% pacient neturjo mioklonini traukuli bent 6 mnesius, o 21, 0% pacient neturjo traukuli bent 1 metus.